Oncozenge AB Capital Reinvestment Ratio

Latest as of September 2021: 108.17x

Oncozenge AB capital reinvestment ratio. Oncozenge AB (ONCOZ) has a Capital Reinvestment Ratio of 108.17x as of September 2021, meaning it reinvests 108% of its operating cash flow (Skr12.00K) in capital expenditures (Skr1.30 Million). Check ONCOZ cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

108.17x

Capex / Operating Cash Flow

Operating Cash Flow

Skr12.00K

SEK

Capital Expenditures

Skr1.30 Million

SEK

Data as of

Sep 2021

Most recent filing

Oncozenge AB Capital Reinvestment Ratio by Year (None–None)

Oncozenge AB capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see ONCOZ cash generation efficiency.

Year	Reinvestment Ratio	Operating CF (SEK)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow